Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

The burden of hyaline membrane disease, mortality and its determinant factors among preterm neonates admitted at Debre Tabor General Hospital, North Central Ethiopia: A retrospective follow up study

Abstract

Background

Hyaline membrane disease (HMD) is a leading cause of morbidity and mortality in preterm newborn babies. Though, there are studies related to Hyaline membrane disease inclusive of all neonates, studies related to the burden among preterm neonates were limited. In addition, increasing neonatal mortality in Ethiopia could be related to increase in the burden of hyaline membrane disease among preterm neonates. Therefore, this study was aimed to assess the burden of hyaline membrane disease, mortality and its associated factors among preterm neonate admitted at neonatal intensive care unit, North Central Ethiopia.

Methodology

An institution-based retrospective follow-up study was conducted among 535 preterm neonates admitted at neonatal intensive care unit from January 1, 2014-December 30, 2017. Data were entered into EPi-data 4.2.0.0 and transferred to STATA version 14 statistical software for statistical analysis. Binary logistic regression was used for the analysis. All variables with P-value < 0.25 during bi-variable analysis were considered for multivariable logistic regression. Level of statistical significance was declared at P value ≤0.05.

Results

In the current study, proportion of hyaline membrane disease was 40% (95% CI; 35.8, 44.3) of which 49.5% died. Preterm neonate born with Gestational age of less than 34 weeks of age (Adjusted odd ratio (AOR = 2.64; 95 CI: 1.49, 4.66)), 5th minute Apgar score less than 7 (AOR = 2.2; 95% CI: 1.20, 4.07), and newborn with birth weight of less than 1500 gram (AOR = 2.4, 95% CI: 1.3, 4.3) were predictors of hyaline membrane disease.

Conclusions

The mean gestational age (±) was 33.46 (±2.55) weeks. The incidence of hyaline membrane disease among preterm admissions was high. Preterm neonate born with gestational age of less than 34 weeks of age, asphyxiated newborns and newborn with birth weight of less than 1500 gram were predictors of hyaline membrane disease. So, emphasis should be given on early screening, follow up and timely interventions for preterm neonate.

Citation: Minuye Birihane B, Alebachew Bayih W, Yeshambel Alemu A, Belay DM, Demis A (2021) The burden of hyaline membrane disease, mortality and its determinant factors among preterm neonates admitted at Debre Tabor General Hospital, North Central Ethiopia: A retrospective follow up study. PLoS ONE 16(3): e0249365. https://doi.org/10.1371/journal.pone.0249365

Editor: Kazumichi Fujioka, Kobe University Graduate School of Medicine School of Medicine, JAPAN

Received: September 22, 2020; Accepted: March 13, 2021; Published: March 30, 2021

Copyright: © 2021 Minuye Birihane et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting Information files.

Funding: The authors received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

List of abbreviations: AOR, Adjusted Odd Ratio; ANC, Antenatal Care; APH, Antepartum Hemorrhage; CI, Confidence Interval; DTH, Debre Tabor Hospital; HMD, Hyaline membrane disease; IRERC, Institutional Research Ethics Review Committee; LBW, Low Birth Weight; NICU, Neonatal Intensive Care Unit; PPROM, Pre labor premature rupture of membranes; NRDS, Neonatal Respiratory Distress Syndrome; SDG, Sustainable development goal; WHO, World Health Organization

Background

More than a third of newborn deaths are related to preterm birth complications. Hyaline membrane disease (Neonatal respiratory distress syndrome (NRDS) is one of the commonest health problem encounter in preterm neonates and typically worsen within the first 48 to 72 hours [1, 2]. It is diagnosed based on the presence of one or more of the following signs: an abnormal respiratory rate, expiratory grunting, nasal flaring, chest wall recessions and thoracic-abdominal asynchrony with or without cyanosis [3–5].

Being born preterm increases risk of dying because of immature organs [6, 7]. Hyaline membrane disease (HMD) is the leading cause of mortality and morbidity in preterm newborn babies [8–12], 45% of cause of death in Ethiopia [13], 46.9% in Nigeria [14], 12.8% in Poland [15]. In addition, the burden of NRDS among neonates reported as 52.9% of total admission in Egypt [16], 26.2% in Nigeria [14], 34.7% in Iraq [17], 57% in north India [18], 23.5% in nepal [19],11.9% in Jimma [20].

About three-quarter of preterm neonates could survive, if they had access to early screening and care [21]. Even though, provision of advanced care for preterm neonates, and mothers; the world health recommendations of surfactant replacement therapy for preterm neonates and corticosteroid administration for mother at risk of preterm birth [22–27], care during pregnancy and childbirth [28, 29], and high flow of nasal oxygen therapy [30]; the burden of HMD related morbidity and mortality is increasing. Preterm mortality is continuing to be one of the global agendas in the sustainable development goals [31].

Based on different studies; gestational age [32], vitamin D status [33], male babies, previous birth of a baby with HMD, cesarean delivery [3, 34, 35], perinatal asphyxia, cold stress, perinatal infection, infants of diabetic mothers [36, 37],abnormal placental implantation [38, 39] were reported as risk factors for hyaline membrane disease.

Though, there are studies related to HMD inclusive of all neonates, studies related to the burden among preterm neonates were limited. In addition, increasing neonatal mortality in Ethiopia could be related to increase in the burden of hyaline membrane disease. Therefore, thestudy was aimed atassessing the burden of hyaline membrane disease, mortality and its associated factors among preterm neonate admitted at neonatal intensive care unit, North Central Ethiopia.

Methodology

Study design, period, setting, and population

An institutional based retrospective follow-up study was conducted among 535 preterm neonate with a study period from January 1, 2014-December 30,201. All preterm neonates admitted at Debre Tabor General Hospital during the study period were included. Debre Tabor town is found 666 km far from Addis Ababa, capital city of Ethiopia. The hospital receives a patient with severe disease referred from the nearby Primary Hospitals and Health Centers which is also true for neonatal care. The hospital provide health care service for more than 2.4 million populations in its catchment area. The hospital has a Neonatal Intensive Care Unit (NICU) with a total of 21 neonatal beds and approximately 1,159 neonates were admitted per year. Most of the neonatal admissions were associated with prematurity [40].

Sample size determination and sampling procedure

A total of 614 preterm neonates admitted during the study period. Of these, medical charts were not available for 25 neonates and 54 charts were excluded due to data incompleteness. Finally, 535 preterm neonates were involved in the study. A list of medical record number was found from Neonatal registration book. Then, charts were found from medical record office by using medical chart number.

Data collection

Data were collected based on the structured data abstraction sheet from medical charts. Abstraction sheet includes maternal socio-demographic, obstetric, and neonatal-related variables by considering hyaline membrane as an outcome variable.

Variables

Dependent variable.

Hyaline membrane disease (Yes, No).

Independent variables.

  1. ✓ Socio-demographical characteristics of the mother (Age of the mother, Residence of the mother
  2. ✓ Obstetric related factors(Gestational age, Gravidity, Parity, ANC follow up, medical/surgical complications (Preeclampsia/Eclampsia, APH, Chorioamnionitis)
  3. ✓ Intrapartum factor (Preterm premature rupture of membrane, place of delivery, Weight of the infant at delivery, multiple pregnancies, mode of delivery)
  4. ✓ Neonatal related factor (Sex of the neonate, Apgar score, and birth order)

Operational definitions

Maternal complication was considered if mother had an obstetric hemorrhage, puerperal sepsis and pyrexia, prolonged labor, eclampsia and preeclampsia, mal-presentation and mal-position, premature rupture of membrane (PROM), cord prolapse, obstructed labor, cephalopelvic disproportion, emergency cesarean section, and retained placenta.

Hyaline membrane disease was diagnosed based on the presence of one or more of the following signs: an abnormal respiratory rate, expiratory grunting, nasal flaring, chest wall recessions and thoraco-abdominal asynchrony with or without cyanosis [3].

Data quality control

Pretest was done on 5% of the sample size. One day training was given for data collectors and supervisors on data collection tools and data collection procedures. Completeness of each data collection tool had been checked on a daily base. Double data entry was done by two data clerks and consistency of the entered data was cross-checked.

Statistical analysis

Data were entered, coded, cleaned, and checked by Epi Data version 4.2.0.0 and analyzed using STATA Version 14 statistical software. Descriptive statistics of included variables were presented by using tables and texts. Binary logistic regression was used to saw the association between each independent variable with a dependent variable. All variables with a p-value≤0.25 in the bi-variable analysis were entered into multivariable analysis. Variables with p values ± 0.05 in multivariable logistic regression model analysis was considered as statistically significant.

Ethical considerations

Ethical clearance was obtained from the Institutional Health Research Ethics Review Committee of Haramaya University, Ethiopia. Then, official letter was written to Debre Tabor General Hospital for permission. The neonates’ name and medical record identification information were not collected. Since the data obtained from medical charts, all data were fully anonymized. All data extracted from the chart were kept strictly confidential.

Result

Sociodemographic and obstetric characteristics of the mother and neonate

The mean age with standard deviation (±SD) of mother was 27.56 (±6.54) years. Sixty-six percent, of mothers were in the age group of 20–34 years. The majority, (72.7%) of them were from the rural area. Seventy-seven percent, (77.1%) of mothers had ante-natal care (ANC) follow-up. Sixty-nine percent of preterm neonates were single births. More than half, 51.6% were male newborn with mean gestational age (±) of 33.46(±2.55) weeks (Table 1).

thumbnail
Download:
Table 1. Maternal and neonatal related characteristics who had preterm neonatal admission at Debre Tabor General Hospital NICU, Northwest Ethiopia, from January 1, 2014–December 30, 2017.

https://doi.org/10.1371/journal.pone.0249365.t001

Proportion of hyaline membrane disease

In the current study, the incidence of hyaline membrane disease was 40.0% (95% CI; 35.8, 44.3); among this 49.5% (106 per 214) were died.

Predictors of hyaline membrane disease

Both bi-variable and multivariable logistic regression were undertaken. In binary logistic regression gestational age, number of antenatal care visit, parity, birth order, birth weight, maternal complications, APH, 5th minute Apgar score and PPROM were significantly associated with HMD. Whereas, in multivariable analysis; Gestational age, 5th minute Apgar score and birth weight were statistically significant.

In this study, newborn with less than 34 weeks of gestation were 2.64 times more likely to develop hyaline membrane disease than neonates born greater than or equal to 34 weeks of gestation (AOR = 2.64; 95 CI:1.49,4.66). Similarly preterm neonate born with less than 7 APGAR score of 5th minute were 2.2 times more likely to have hyaline membrane disease in contrast with newborns with APGAR score of greater than seven (AOR = 2.2; 95% CI:1.20,4.07).

Those preterm neonates born with birth weight of less than 1500 gram were 2.4 times more likely to have hyaline membrane disease than newborn with birth weight of greater than 1500 gram (AOR = 2.4,95% CI:1.3,4.3) (Table 2).

thumbnail
Download:
Table 2. Predictors of hyaline membrane disease admitted in NICU, Debretabor General Hospital, from January 1, 2014-December 30, 2017.

https://doi.org/10.1371/journal.pone.0249365.t002

Discussion

Hyaline membrane disease is one of the significant predictor of neonatal morbidity and mortality. In this study proportion of hyaline membrane disease was 40%, this is consistent with study conducted in Iraq, 42.2% [17], in Black lion Hospital, Ethiopia 42.9% [41]. But, higher than study conducted in Nigeria, 26.2% [14], in Bulgaria, 15% [42], in Nepal 17.8% [43], in Jimma Ethiopia 11.9% [20].This could be the current study include only preterm neonates. In addition, the study conducted in Bulgaria was conducted among preterm neonate whose mother took dexamethasone. However, proportion was lower than the study conducted, in Cameroon 47.5% [3], 54,3% in Poland [15], 54.7% Saudi Arabia [44], 49.6% in Egypt [45]. The possible reasons could be the study conducted in Poland was conducted among preterm births from PROM mother which may increase the burden. In addition, it could be a difference in the study setting, period, and socio economic difference between the countries.

In multi variable analysis those with gestational age of less than 34 weeks of age, asphyxiated newborns and newborn with birth weight of less than 1500gram were predictors of hyaline membrane disease. In the current study, newborn with less than 34 weeks of gestation were more likely to develop hyaline membrane disease than neonates born greater than or equal to 34 weeks of gestation. This is consistent with study conducted in China [46], and India [47].The reason could be as gestational age increase hormonal level of serum TSH levels increase which have an impact on lowering incidence of NRDS [48]. In addition, as the gestational age decrease the probability of being borne with low Apgar score increase [49], which increase HMD. Moreover, surfactant deficiency is more common in preterm neonate delivered before 34 weeks of gestation. Thus, identifying and providing critical care for preterm neonates with gestational age less than 34 weeks of gestation has to be practiced. In addition, non-natural surfactant administration should be considered for preterm neonates’ gestational age less than 34 weeks.

Preterm neonates born with 5th minute Apgar score of less than 7 were more likely to have hyaline membrane disease in contrast with newborns with Apgar score of greater than seven. This is similar to studies conducted in UK [50], USA [51], Cameroon [3], China [46], and Adis Ababa [41]. This could be because of the fact that low Apgar score result in birth asphyxia and low level red cell mass which interfere with cardio-respiratory adaptation result in increases the risk of Hyaline membrane disease [52, 53]. Those preterm neonates born with birth weight of less than 1500 gram were 2.4 times more likely to have respiratory syndrome than newborn with birth weight of greater than 1500 gram. This is consistent with a study conducted in Italy [34].The rational could be low birth weight neonates have high risk to have immaturity of physiological and anatomical structures such as; deficient in surfactant, lack of subcutaneous tissue, large surface area to body mass ratio, and fragile capillaries in their brain [54]. Hence, deficiency in surfactant administration increases the risk of pulmonary edema which results in Hyaline membrane disease. To decrease the burden related to hyaline membrane disease the hospital should give emphasis on treatment strategies of HMD. Nowadays, the hospital is implementing treatment strategies for neonate with HMD such as nasal continuous positive airway pressure by mask, nasal prong, nasopharyngeal tube; high flow nasal cannula and oxygen supplement. However, the hospital is not implementing surfactant administration. Therefore, the hospital should give emphasis on early screening, update and integrating other treatment strategies (surfactant administration) for HMD neonates as per the protocol. Surfactant administration will be based a combination of clinical, radiological, or laboratory findings (neonates with clinical and radiographic evidence of RDS, neonates at risk of developing RDS (e.g. <32 weeks or low birth weight <1300g or neonates who are intubated, regardless of gestation, and requiring FiO2 >40%).

Since, the study is retrospective follow-up study important variables like surfactant administration, Vitamin D status of the newborn and placental abnormality were missed. Therefore, future researcher should do prospective studies by including those variables which may have key indicators for HMD.

Conclusions

The incidence of hyaline membrane disease among preterm birth was high. Preterm neonate born with gestational age of less than 34 weeks of age, asphyxiated newborns and newborn with birth weight of less than 1500 gram were predictors of hyaline membrane disease. So, emphasis should be given on early screening, follow up and timely interventions of preterm neonates borne with low birth weight and low Apgar score.

Acknowledgments

The authors acknowledged Debretabor General Hospital, and data collectors.

References

  1. 1. Hiles M., et al., Neonatal respiratory distress syndrome: chest X-ray or lung ultrasound? A systematic review. Ultrasound, 2017. 25(2): p. 80–91. pmid:28567102
  2. 2. Dyer J., Neonatal respiratory distress syndrome: tackling a worldwide problem. Pharmacy and Therapeutics, 2019. 44(1): p. 12. pmid:30675087
  3. 3. Tochie J.N., et al., Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes. Pan African Medical Journal, 2016. 24(1).
  4. 4. Pang H., et al., Diagnostic value of lung ultrasound in evaluating the severity of neonatal respiratory distress syndrome. European journal of radiology, 2019. 116: p. 186–191. pmid:31153563
  5. 5. Monica N.F., et al., Recent understanding of Pathophysiology, Risk factors and treatments of Neonatal Respiratory Distress Syndrome: A review. Sci Lett, 2017. 5(1): p. 70–78.
  6. 6. Kliegman R.M. and Nelson W.E., Nelson textbook of pediatrics. 2016, Philadelphia: Elsevier.
    • 7. Rennie J.M. and Roberton N.R.C., Rennie and Roberton’s textbook of neonatology. 2012, Edinburgh: Churchill Livingstone/Elsevier.
      • 8. Hadgu F.B., et al., Prevalence and Factors Associated with Neonatal Mortality at Ayder Comprehensive Specialized Hospital, Northern Ethiopia. A Cross-Sectional Study. Pediatric Health, Medicine and Therapeutics, 2020. 11: p. 29. pmid:32095090
      • 9. Alemu A.Y., et al., Determinants of neonatal mortality at neonatal intensive care unit in Northeast Ethiopia: unmatched case-control study. Tropical Medicine and Health, 2020. 48(1): p. 1–10. pmid:32514229
      • 10. Wolde H.F., et al., Factors affecting neonatal mortality in the general population: evidence from the 2016 Ethiopian Demographic and Health Survey (EDHS)—multilevel analysis. BMC research notes, 2019. 12(1): p. 610. pmid:31547855
      • 11. Yismaw A.E., Gelagay A.A., and Sisay M.M., Survival and predictors among preterm neonates admitted at University of Gondar comprehensive specialized hospital neonatal intensive care unit, Northwest Ethiopia. Italian journal of pediatrics, 2019. 45(1): p. 4. pmid:30616641
      • 12. Alebel A., et al., Neonatal mortality in the neonatal intensive care unit of Debre Markos referral hospital, Northwest Ethiopia: a prospective cohort study. BMC pediatrics, 2020. 20(1): p. 1–11. pmid:31900152
      • 13. Muhe L.M., et al., Major causes of death in preterm infants in selected hospitals in Ethiopia (SIP): a prospective, cross-sectional, observational study. The Lancet Global Health, 2019. 7(8): p. e1130–e1138. pmid:31303299
      • 14. Adebami O.J., et al., Determinants of outcome in newborns with respiratory distress in Osogbo, Nigeria. Int J Res Med Sci, 2017. 5(4): p. 1487–1493.
      • 15. Rijal P. and Shrestha M., Analysis of Neonatal Respiratory Distress in Neonatal Intensive Care Unit at Nepal Medical College. Journal of Nepal Health Research Council, 2018. 16(2): p. 131–135. pmid:29983424
      • 16. Abou-Faddan H.H. and Abdelaziz N., Respiratory Distress and Its Outcome among Neonates Admitted to Neonatal Intensive Care Unit of Assiut University Children Hospital, Egypt. Egypt The Egyptian Journal of Community Medicine, 2018. 36(2).
      • 17. Ajeli M.H.A., Prevalence and Etiology of Respiratory Distress in Newborns in the Fallujah Teaching Hospital for Women and Children. Karbala Journal of Medicine, 2019. 12(2): p. 2199–2202.
      • 18. Sahoo T., et al., Outcome of extremely low birth weight (ELBW) infants from a birth cohort (2013–2018) in a tertiary care unit in North India. Journal of Perinatology, 2020. 40(5): p. 743–749. pmid:32060359
      • 19. Shrestha S., et al., Outcome of preterm babies and associated risk factors in a hospital. Journal of the Nepal Medical Association, 2010. 50(180). pmid:22049892
      • 20. Bayana, E., et al., Pattern of disease & associated factors among neonates admitted to neonatal intensive care unit at jimma university medical center, jimma, Southwest Ethiopia.
        • 21. CDC, Preterm Birth.https://www.cdc.gov/features/premature birth/index.Html. accessed date october 10/2017. 2017.
          • 22. Manandhar S.R., Outcome of surfactant replacement therapy in preterm babies with hyaline membrane disease at neonatal intensive care unit of a tertiary hospital. Birat Journal of Health Sciences, 2018. 3(3): p. 537–541.
          • 23. Johansson J. and Curstedt T., Synthetic surfactants with SP‐B and SP‐C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases. Journal of Internal Medicine, 2019. 285(2): p. 165–186. pmid:30357986
          • 24. WHO, WHO recommendations on interventions to improve preterm birth outcomes.http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/preterm-birth-guideline/en/.accessed on october2/2017 2015.
            • 25. Mihaylova A., et al., Prevention of hyaline membrane disease (hmd) in preterm infants. World J Pharmacy Pharm Sci, 2016. 5: p. 9–16.
            • 26. Delara M., et al., Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Archives of Disease in Childhood-Fetal and Neonatal Edition, 2019. 104(2): p. F137–F144. pmid:29666203
            • 27. Sweet D.G., et al., European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology, 2017. 111(2): p. 107–125. pmid:27649091
            • 28. Requejo J., et al., Born Too Soon: Care during pregnancy and childbirth to reduce preterm deliveries and improve health outcomes of the preterm baby. Reproductive health, 2013. 10(S1): p. S4. pmid:24625215
            • 29. Abdelazim I., et al., Impact of antenatal oxytocin infusion on neonatal respiratory morbidity associated with elective cesarean section. Archives of Medical Science: AMS, 2017. 13(3): p. 629. pmid:28507580
            • 30. Di Mauro A., et al., Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: a single center experience. Italian journal of pediatrics, 2017. 43(1): p. 116. pmid:29282094
            • 31. Liu L., et al., Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. The Lancet, 2015. 385(9966): p. 430–440.
            • 32. Al Riyami N., et al., Respiratory Distress Syndrome in Neonates Delivered at Term-gestation by Elective Cesarean Section at Tertiary Care Hospital in Oman. Oman Medical Journal, 2020. 2020(35): p. e133. pmid:32607253
            • 33. Al‐Beltagi M., et al., Vitamin D status in preterm neonates and the effects of its supplementation on respiratory distress syndrome. Pediatric Pulmonology, 2020. 55(1): p. 108–115. pmid:31815370
            • 34. Condò V., et al., Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? The Journal of Maternal-Fetal & Neonatal Medicine, 2017. 30(11): p. 1267–1272. pmid:27399933
            • 35. Anadkat J., et al., Increased risk for respiratory distress among white, male, late preterm and term infants. Journal of Perinatology, 2012. 32(10): p. 780–785. pmid:22222548
            • 36. Li Y., Wang W., and Zhang D., Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome: a meta-analysis. Acta diabetologica, 2019: p. 1–12. pmid:30955125
            • 37. Mortier I., et al., Is gestational diabetes an independent risk factor of neonatal severe respiratory distress syndrome after 34 weeks of gestation? A prospective study. Archives of Gynecology and Obstetrics, 2017. 296(6): p. 1071–1077. pmid:28948345
            • 38. Spillane N.T., et al., Increased incidence of respiratory distress syndrome in neonates of mothers with abnormally invasive placentation. PloS one, 2018. 13(7): p. e0201266. pmid:30048504
            • 39. Ahn K.H., et al., Anterior placenta previa in the mid-trimester of pregnancy as a risk factor for neonatal respiratory distress syndrome. PloS one, 2018. 13(11): p. e0207061. pmid:30388184
            • 40. DTH, Debretabor General Hospital Report 2009 EC. 2017.
              • 41. Aynalem Y.A., et al., Incidence of respiratory distress and its predictors among neonates admitted to the neonatal intensive care unit, Black Lion Specialized Hospital, Addis Ababa, Ethiopia. PloS one, 2020. 15(7): p. e0235544. pmid:32609748
              • 42. Mihaylova A., et al., Frequency of hyaline membrane disease in preterm infants after prenatal corticosteroid prophylaxis. 2018.
              • 43. Adhikari J., Aryal S., and Gupta V., Acute Respiratory Distress and Its Risk Factors among Neonates Admitted in a Tertiary Care Center of Western Nepal. Journal of Nepalgunj Medical College, 2017. 15(1): p. 5–8.
              • 44. Qari S.A., et al., Prevalence of respiratory distress syndrome in neonates. The Egyptian journal of hospital medicine, 2018. 70(2): p. 257–264.
              • 45. Baseer K.A.A., Mohamed M., and Abd-Elmawgood E.A., Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt. Annals of Global Health, 2020. 86(1): p. 22–22. pmid:32140431
              • 46. Wang J., et al., Risk factors for respiratory distress syndrome among Chinese infants of 34–42 weeks gestational age: a multi-center observational study. Int J Clin Exp Med, 2019. 12(4): p. 60–4354.
              • 47. Gagrani S., et al., Effect of gender and gestational age on short term morbidities and mortality in extremely low birth neonates. International Journal of Contemporary Pediatrics, 2017. 4(3): p. 993.
              • 48. Kim Y.J., Kim B.K., and Kim Y.H., Association between Thyroid Stimulating Hormone and Respiratory Distress Syndrome of Newborn in the Preterm Infants. 2020.
              • 49. Seikku L., et al., Asphyxia, neurologic morbidity, and perinatal mortality in early-term and postterm birth. Pediatrics, 2016. 137(6).
              • 50. Iliodromiti S., et al., Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. The Lancet, 2014. 384(9956): p. 1749–1755. pmid:25236409
              • 51. Shen C.L., et al., Genetic factors contribute to risk for neonatal respiratory distress syndrome among moderately preterm, late preterm, and term infants. The Journal of pediatrics, 2016. 172: p. 69–74. e2.
              • 52. Ehrenstein V., Association of Apgar scores with death and neurologic disability. Clinical epidemiology, 2009. 1: p. 45. pmid:20865086
              • 53. Sabol B.A. and Caughey A.B., Acidemia in neonates with a 5-minute Apgar score of 7 or greater–What are the outcomes? American journal of obstetrics and gynecology, 2016. 215(4): p. 486. e1-486. e6. pmid:27255470
              • 54. Dhaded S.M.e. and Somannavar M.S., Neonatal mortality and coverage of essential newborn interventions 2010–2013: a prospective, population-based study from low-middle income countries. Reprod Health, 2015. 12 Suppl 2: p. S6. pmid:26063125